Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 3 - Accumulated Other Comprehensive (Loss) Income

Note 3 - Accumulated Other Comprehensive (Loss) Income

9 Months Ended

Sep. 30, 2025

Comprehensive Income (Loss) Note [Text Block]

3. Accumulated Other Comprehensive (Loss) Income

The Company's accumulated other comprehensive (loss) income consists of the accumulated net unrealized gains or losses on foreign currency translation adjustments.

The change in accumulated other comprehensive (loss) income presented on the condensed consolidated balance sheets for the three months ended September 30, 2025 and 2024 is reflected in the table below net of tax:

	*Three Months Ended September 30,*
	*2025*			*2024*
Balance at beginning of period	$	(683	)	$	539
Net unrealized loss on foreign currency translation		(17	)		(527	)
Balance at end of period	$	(700	)	$	12

The change in accumulated other comprehensive (loss) income presented on the condensed consolidated balance sheets for the nine months ended September 30, 2025 and 2024 is reflected in the table below net of tax:

	*Nine Months Ended September 30,*
	*2025*			*2024*
Balance at beginning of period	$	957		$	156
Net unrealized loss on foreign currency translation		(1,657	)		(144	)
Balance at end of period	$	(700	)	$	12